Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 20 of 29

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Glucocorticoid Receptor Polymorphisms and Corticosteroid–Induced Glaucoma

S.G. Schwartz; S. Gerzenstein; J. Ayala–Haedo; M. Polk; A.S. Venkatraman; C.A. Puliafito; M.E. Fini

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):205.

ARVO Annual Meeting Abstract May 2006

Segmentation of Spectral–Domain Optical Coherence Tomography Images of the Inner Surface of the Retina in the Presence of Epiretinal Membranes

J.E. Legarreta; R.W. Knighton; G. Gregori; G. Lalwani; C.A. Puliafito

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5674.

ARVO Annual Meeting Abstract May 2006

Optical Coherence Tomography Findings in a Variable–Dosing Regimen with Ranibizumab (LucentisTM): The PrONTO Study

G. Lalwani; A.E. Fung; S. Michels; A.S. Venkatraman; C.A. Puliafito; P.J. Rosenfeld

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2147.

ARVO Annual Meeting Abstract May 2006

Assessment of Internal Reflectivity of the Various Cellular Layers of the Retina Using Optical Coherence Tomography

D. Cabrera; H.M. Salinas; C.A. Puliafito; R.W. Knighton

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2630.

ARVO Annual Meeting Abstract May 2006

Evaluation of Potential Pitfalls Related to Operator Errors During OCT Image Acquisition

G. Somfai; C.E. Denis; H.M. Salinas; Z.Z. Nagy; J. Németh; C.A. Puliafito; D. Cabrera

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2631.

ARVO Annual Meeting Abstract May 2006

Visual Acuity Outcomes Following a Variable–Dosing Regimen for Ranibizumab (LucentisTM) in Neovascular AMD: The PrONTO Study

P.J. Rosenfeld; A.E. Fung; G.A. Lalwani; S. Michels; A.S. Venkatraman; C.A. Puliafito

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2958.

ARVO Annual Meeting Abstract May 2006

Reconstruction of 3D Fundus Angiogram From Spectral–Domain Optical Coherence Tomography Images

C. Wu; S. Jiao; G. Gregori; R.W. Knighton; C.A. Puliafito

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3305.

ARVO Annual Meeting Abstract May 2006

Mapping the Nerve Fiber Layer and Ganglion Cell Layer Geometry with Spectral–Domain Optical Coherence Tomography

G. Gregori; R.W. Knighton; S. Jiao; J.E. Legarreta; N. Sekhon; D.L. Budenz; D.R. Anderson; C.A. Puliafito

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3350.

ARVO Annual Meeting Abstract May 2006

The Bascom Palmer Eye Institute Pediatric OCT System: A Concept

A.N. Moshfeghi; C. McKeown; A. Berrocal; W. Lee; R. Will; A. Bernal; S. Uhlhorn; F. Manns; C.A. Puliafito; J.–M. Parel

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3502.

ARVO Annual Meeting Abstract May 2006

Detecting Diabetic Retinal Pathology in a Single Image, Ultra Wide Angle Fluorescein Angiography (Optos Panoramic 200A) vs Conventional Imaging

J.Y. Yu; T.R. Friberg; S.D. Schwartz; C.A. Puliafito; A. Gupta; I.J. Suner

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4023.

ARVO Annual Meeting Abstract May 2006

High–Density Image Registration and Retinal Blood Vessel Study in Ophthalmic Spectral–Domain OCT

S. Jiao; C. Wu; X. Huang; G. Gregori; R. Knighton; C.A. Puliafito

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4056.

ARVO Annual Meeting Abstract May 2005

Non–infectious Pseudohypopyon Following Intravitreal Triamcinolone Acetonide (IVTA) Injection

H.W. Flynn; A.A. Moshfeghi; J.L. Davis; J.W. Kitchens; T.G. Murray; C.A. Puliafito; P.J. Rosenfeld; I.U. Scott; W.E. Smiddy

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):486.

ARVO Annual Meeting Abstract May 2005

3–D OCT Maps of Retinal Pathologies

G. Gregori; R.W. Knighton; S. Jiao; X. Huang; P.J. Rosenfeld; C.A. Puliafito

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1055.

ARVO Annual Meeting Abstract May 2005

Macula Mapping and Simultaneous Acquisition of Sectional and Fundus Ophthalmic Images With Three–Dimensional Spectral–Domain Optical Coherence Tomography

S. Jiao; R. Knighton; G. Gregori; X. Huang; C.A. Puliafito

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1114.

ARVO Annual Meeting Abstract May 2005

Optical Coherence Tomography (OCT) Outcomes Following Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration

C.A. Puliafito; P.J. Rosenfeld; S. Michels; A.A. Moshfeghi; A.E. Fung; K.D. Rosenberg; A.S. Venkatraman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1376.

ARVO Annual Meeting Abstract May 2005

Indocyanine Green Angiographic Outcomes Following Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration

K.D. Rosenberg; P.J. Rosenfeld; C.A. Puliafito; S. Michels; A.A. Moshfeghi; A.E. Fung

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1377.

ARVO Annual Meeting Abstract May 2005

Safety of Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration

S.M. Michels; P.J. Rosenfeld; C.A. Puliafito; A.A. Moshfeghi; A.E. Fung; K.D. Rosenberg; E.N. Marcus; A.S. Venkatraman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1378.

ARVO Annual Meeting Abstract May 2005

Durability of Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration

A.A. Moshfeghi; P.J. Rosenfeld; C.A. Puliafito; S. Michels; A.E. Fung; K.D. Rosenberg; A.S. Venkatraman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1381.

ARVO Annual Meeting Abstract May 2005

Fluorescein Angiographic Outcomes Following Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration

A.E. Fung; P.J. Rosenfeld; C.A. Puliafito; S. Michels; A.A. Moshfeghi; K.D. Rosenberg; E.N. Marcus; A.S. Venkatraman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1382.

ARVO Annual Meeting Abstract May 2005

Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration (SANA) Study: Visual Acuity Outcomes

P.J. Rosenfeld; C.A. Puliafito; S. Michels; A.A. Moshfeghi; A.E. Fung; K.D. Rosenberg; E.N. Marcus; A.S. Venkatraman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):2310.

1 2

Next 20 Results »

Advertisement